The closest human evidence in its drug class is Athira Pharma's fosgonimeton (ATH-1017), a structurally distinct molecule in the same HGF/c-Met program whose Phase 2/3 LIFT-AD Alzheimer's trial failed its primary endpoint in September 2024 (GST 0.08, P=.70)
Based on our expert opinion, B12/MIC is fine to use short-term or long-term, depending on your health goals
Given the negative results of other laboratory tests, Hashimotos thyroiditis, a primary organ-specific autoimmune disease associated with positive ANA, may be the underlying cause of the patients positive ANA test
Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO
To understand how this fits into the broader picture of amino acid chains, you can read this foundational guide to peptides